Area of research
Infectious Diseases · Immunology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Research on Leishmaniasis Studies, and Immunotherapy and Immune Responses.
Activity of a Three-Phage Combination against Mycobacterium Tuberculosis in Disease-Relevant Conditions
Activity of a three-phage combination against
<i>Mycobacterium tuberculosis</i>
in disease-relevant conditions
The Sm14+GLA-SE Recombinant Vaccine Against <i>Schistosoma mansoni</i> and <i>S. haematobium</i> in Adults and School Children: Phase II Clinical Trials in West Africa.
Infant Antibodies After Maternal COVID-19 Vaccination During Pregnancy or Postpartum
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent.
Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk
Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants
Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum.
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis?
Homologous and Heterologous Covid-19 Booster Vaccinations
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against <i>Mycobacterium avium</i> infection but is ineffective as an adjunct to antibiotic treatment in chronic disease.
Characterizing in vivo loss of virulence of an HN878 Mycobacterium tuberculosis isolate from a genetic duplication event
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model.
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Diagnostics and the neglected tropical diseases roadmap: setting the agenda for 2030
The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.
Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research
Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis
Dissecting Mechanisms of Immunodominance to the Common Tuberculosis Antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ)